Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI

Purpose The aim of this study is to evaluate the impact of weight loss at presentation on treatment outcomes of first-line EGFR-tyrosine kinase inhibitors (EGFR-TKI) in EGFR-TKI sensitive mutant NSCLC patients. Methods We retrospectively analyzed the clinical outcomes of 75 consecutive advanced NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820920/
https://www.ncbi.nlm.nih.gov/pubmed/29483958
http://dx.doi.org/10.7150/jca.22378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820920/
https://www.ncbi.nlm.nih.gov/pubmed/29483958
http://dx.doi.org/10.7150/jca.22378

Ejemplares similares